SST-024

N/A

Report date: 2024/07/01 17:40:01
NME

Base Information

Drug NameSST-024
Drug Alias NameSST-024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase I isoform alpha activators
TargetsCasein kinase I isoform alpha
Therapy Area/IndicationsAdenomatous Polyposis Coli
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStemSynergy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStemSynergy Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAdenomatous Polyposis Coli
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A